FI941345A0 - Retinoids and their use in the treatment of skin diseases and leukemia - Google Patents

Retinoids and their use in the treatment of skin diseases and leukemia

Info

Publication number
FI941345A0
FI941345A0 FI941345A FI941345A FI941345A0 FI 941345 A0 FI941345 A0 FI 941345A0 FI 941345 A FI941345 A FI 941345A FI 941345 A FI941345 A FI 941345A FI 941345 A0 FI941345 A0 FI 941345A0
Authority
FI
Finland
Prior art keywords
retinoids
leukemia
treatment
skin diseases
diseases
Prior art date
Application number
FI941345A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI941345A (en
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941345A publication Critical patent/FI941345A/en
Publication of FI941345A0 publication Critical patent/FI941345A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/80—Phthalic acid esters
    • C07C69/82—Terephthalic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/86—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI941345A 1991-09-24 1994-03-23 Retinoids and their use in the treatment of skin diseases and leukemia FI941345A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76457891A 1991-09-24 1991-09-24
PCT/US1992/006485 WO1993006086A1 (en) 1991-09-24 1992-08-10 Retinoids and their use in treating skin diseases and leukemia

Publications (2)

Publication Number Publication Date
FI941345A FI941345A (en) 1994-03-23
FI941345A0 true FI941345A0 (en) 1994-03-23

Family

ID=25071126

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941345A FI941345A0 (en) 1991-09-24 1994-03-23 Retinoids and their use in the treatment of skin diseases and leukemia

Country Status (6)

Country Link
EP (1) EP0642499A1 (en)
JP (1) JPH06507178A (en)
CA (1) CA2119571A1 (en)
FI (1) FI941345A0 (en)
PT (1) PT100878A (en)
WO (1) WO1993006086A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420145A (en) * 1993-03-22 1995-05-30 Koichi Shudo Carboxylic acid derivative
ATE195716T1 (en) * 1992-04-22 2000-09-15 Ligand Pharm Inc RETINOID-X RECEPTOR SELECTIVE COMPOUNDS
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
CA2137997A1 (en) * 1994-01-03 1995-07-04 John E. Starrett, Jr. Retinoid-like compounds
US5648385A (en) * 1994-01-03 1997-07-15 Bristol-Myers Squibb Co. Retinoid-like compounds
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5559248A (en) * 1995-04-05 1996-09-24 Bristol-Myers Squibb Co. Retinoid-like heterocycles
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5726191A (en) * 1995-11-16 1998-03-10 Hoffmann-La Roche Inc. Aromatic carboxylic acid esters
WO2000063196A1 (en) * 1999-04-20 2000-10-26 Novo Nordisk A/S New compounds, their preparation and use
WO2022140467A1 (en) * 2020-12-21 2022-06-30 Samson Pharma, Llc Topical compositions and methods of treating skin diseases and conditions with such compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
EP0435222A3 (en) * 1989-12-27 1991-12-11 Hoechst-Roussel Pharmaceuticals Incorporated Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
EP0642499A1 (en) 1995-03-15
CA2119571A1 (en) 1993-04-01
PT100878A (en) 1993-10-29
FI941345A (en) 1994-03-23
JPH06507178A (en) 1994-08-11
WO1993006086A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
FI944549A (en) Compounds useful in the treatment of allergic and inflammatory diseases
DE69318501D1 (en) Eye examination and / or treatment instrument
DE68907553D1 (en) MAKE-UP AGENTS FOR HUMAN USE.
KR890700608A (en) Human interleukin-3 and its muteins
DE69309698D1 (en) SKIN TREATMENT WITH ADHESION-ENHANCING PROPERTIES
IT1222771B (en) UNSATURATED AROMATIC PEROXIDES AND THEIR USE IN THERAPY AND COSMETICS
DK90089A (en) skin treatment composition
FI944600A (en) Imidazol-4-ylpiperidine derivatives, their preparation and their use in therapy
DK295190A (en) COSMETICS AND SKIN TREATMENT COMPOSITIONS
GB2107587B (en) Composition in the form of a shampoo based on anthralin or a derivative thereof and its use in the treatment of skin diseases
FI941345A0 (en) Retinoids and their use in the treatment of skin diseases and leukemia
GB9103075D0 (en) Trinitrobenzene derivatives and their therapeutic use
KR890701004A (en) Preparation of plant with improved physiological effect and use of the plant
ES556492A0 (en) IMPROVEMENTS IN RELAXATION AND SIMILAR SUNBEDS
FI973185A0 (en) Use of melatonin in the treatment of patients with drug dependence
DE59306085D1 (en) HAIR AND BODY TREATMENT
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
ITMI920261U1 (en) VAPORIZER FOR MEDICAL AND COSMETIC PURPOSES
IT1188704B (en) CYCLOALIFATIC UNSATURATED DERIVATIVES, THEIR PREPATATION PROCEDURES AND THEIR USE IN THERAPY AND COSMETICS
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
EP0407788A3 (en) Use of retinoids for the treatment and prophylaxis of immune related diseases
EP0456204A3 (en) Use of benzocycloheptathiophenecarboxylic acid derivatives in the treatment of eosinophile accumulation/activation and connected diseases
NO920961D0 (en) SKIN AND SKIN CARE
NO920003D0 (en) SKIN AND SKIN CARE
DE9319520U1 (en) Chip wound plaster, medical healing plaster with music chip, which is incorporated into the surface that adheres to the skin

Legal Events

Date Code Title Description
FD Application lapsed